We are pleased to announce that our Co-CEO, Dr. Yumoto, will present a poster on Neuron DDS at the 36th International Symposium on ALS/MND (MNDA Symposium).
We are honored to have been given this opportunity to present our cutting edge Neuron DDS technology at one of the largest and most influential international conferences in the ALS/MND research field. Only a limited number of abstracts are accepted each year after a rigorous review process.
[Symposium Details]
Dates: December 5 (Fri) – 7 (Sun), 2025 ※U.S. (PST)
Location: Loews Coronado Bay Resort, San Diego, California, USA
Poster Theme: Pre-clinical Therapeutic Strategies
TST-01:Neuron-selective delivery of oligonucleotides via synaptic vesicle recycling:A strategy to bypass the CNS barrier and optimize intracellular exposure.
In this study, we demonstrated a neuron-targeted delivery system that can transport both oligonucleotides and small-molecule therapeutics using synaptic vesicle recycling as the uptake route to neurons .
This approach enables direct molecular exposure into motor neurons and may offer a practical path to overcoming the long-standing delivery challenges in ALS drug development.
If you will be attending the symposium, we warmly welcome you to visit our poster.
We look forward to discuss our research and explore potential collaboration opportunities with colleagues in the field.